May 2014

Biomed (May 20-22, 2014)

PolyPid participated at Biomed – Israel Innovation Conference, held at the Tel Aviv Fairgrounds, Tel Aviv, Israel, May 20-22, 2014.

Mar 2014

AAOS Annual Meeting (March 11-15, 2014)

Mr. Amir Weisberg PolyPid’s CEO, Prof. David Segal and Mr. Eitan Kiet, participated at the annual meeting of the American Academy of Orthopaedic Surgeons, held in New Orleans, Louisiana, March 11-15, 2014. They met with doctors, thought leaders, and companies.

Mar 2014

7th Annual European Life Science CEO Forum for Partnering & Investing in Biotech & Pharma Industry (March 4-5, 2014)

Dr. Noam Emanuel, PolyPid’s CTO, presented the company at the 7th Annual European Life Science CEO Forum for Partnering & Investing in Biotech & Pharma Industry, held at the Hilton Zurich Airport Hotel, Switzerland, March 4-5, 2014.

Technology

The PLEX™ (Polymer-Lipid Encapsulation matriX) platform is a matrix made of alternating layers of polymers and lipids that allows controlled, local release of unmodified drugs over extended periods of time.

Read More >

D-PLEX100

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

Read More >

D-PLEX1000

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >